Opinion

Video

Clinical Scenario: A 57-Year-Old Woman With Metastatic Breast Cancer

Two oncologists present the clinical scenario of a 57-year-old woman with metastatic HER2-positive breast cancer to discuss their approach for incorporating recent research into clinical decision making around systemic therapy.

The video opens with Laura Spring, a breast medical oncologist from Mass General Cancer Center and Harvard Medical School, welcoming viewers to a program on interpreting the latest data for breast cancer treatment approaches. She introduces her colleague, Dr. Manali Bhave, a breast medical oncologist from Emory University and director of the phase one unit.

Bhave presents a hypothetical patient case of a 57-year-old healthy woman diagnosed with invasive ductal carcinoma in her left breast after a 4cm mass was found on mammogram. The tumor was estrogen, progesterone and HER2 positive with an IHC of 3+. Scans revealed metastatic disease with three 3cm liver lesions and a solitary lung lesion. A liver biopsy confirmed metastatic triple positive breast cancer.

The patient received 6 cycles of docetaxel, trastuzumab, and pertuzumab (THP) followed by maintenance HP. She had a good response with the breast mass shrinking and complete resolution of the liver lesions initially. However, after some time on maintenance HP, she progressed with recurrence of 3 new liver lesions, though her liver enzyme levels remained normal.

Bhave and Spring proceed to discuss how they would approach treating this patient's recurrent metastatic HER2+ breast cancer, incorporating the latest clinical data and pivotal trials in their decision-making process. The case illustrates their real-world application of recent research advances.

This summary was AI-generated and edited for clarity.

Related Videos
Sheldon M. Feldman, MD
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
In this episode of OncChats: Empowering Community Cancer Care, Dr. Rai emphasizes the importance of community outreach and support for patients with cancer, highlighting the need for holistic care that addresses both physiological and psychological aspects of treatment while reinforcing the value of strong relationships between primary care physicians and specialists.
In this episode of OncChats: Empowering Community Cancer Care, Dr. Woodworth sheds light on the “Road to Recovery” survivorship program at Henry Mayo, which supports cancer survivors by providing them with fitness, education, and mental health resources, and underscores the importance of mentorship programs for community providers to ensure equitable cancer care.
In this episode of OncChats: Empowering Community Cancer Care, Drs Woodworth and Rai, discuss their collaborative approach to cancer screening, emphasizing the importance of community efforts and individual assessments in integrating genetic testing and screenings into routine practice.
In this episode of OncChats: Empowering Community Cancer Care, experts discuss the significance of community-based cancer care, emphasizing that most cancers are diagnosed locally and highlighting the importance of collaboration between primary care physicians and specialists to provide optimal education and treatment.